Biohaven Pharmaceutical Holding Co Ltd (BHVN) — Financial Flexibility Index
Biohaven Pharmaceutical Holding Co Ltd (BHVN) has a Financial Flexibility Index of -0.44x as of March 2026. Free cash flow of $-149.92 Million (operating CF $-149.92 Million minus capex $0.00) represents 0% of total liabilities ($336.91 Million). Check Biohaven Pharmaceutical Holding Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biohaven Pharmaceutical Holding Co Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Biohaven Pharmaceutical Holding Co Ltd across 9 annual periods. See working capital to net assets of Biohaven Pharmaceutical Holding Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Biohaven Pharmaceutical Holding Co Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for Biohaven Pharmaceutical Holding Co Ltd. For the full company profile including market capitalisation, see BHVN stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.52x | $-608.72 Million | $-609.44 Million | $399.38 Million | ▲ +49.5% |
| 2024 | -3.02x | $-578.40 Million | $-582.45 Million | $191.67 Million | ▲ +21.7% |
| 2023 | -3.86x | $-328.68 Million | $-331.73 Million | $85.24 Million | ▼ -84.8% |
| 2022 | -2.09x | $-256.62 Million | $-297.69 Million | $123.01 Million | ▲ +31.8% |
| 2021 | -3.06x | $-144.90 Million | $-145.84 Million | $47.37 Million | ▼ -45.0% |
| 2020 | -2.11x | $-73.26 Million | $-75.96 Million | $34.72 Million | ▼ -98.0% |
| 2019 | -1.07x | $-374.80 Million | $-377.33 Million | $351.69 Million | ▲ +23.2% |
| 2018 | -1.39x | $-192.98 Million | $-197.14 Million | $139.09 Million | ▲ +78.0% |
| 2017 | -6.32x | $-94.27 Million | $-94.81 Million | $14.92 Million | — |